As of September 2024, Maxigen Biotech has a market cap of $125.30M. This makes Maxigen Biotech the world's 19921th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $130.43M | -2.89% |
2023 | $134.32M | 1.57% |
2022 | $132.24M | -8.19% |
2021 | $144.03M | 126.64% |
2020 | $63.55M | -9.31% |
2019 | $70.07M | 9.07% |
2018 | $64.24M | 2.43% |
2017 | $62.72M | -4.64% |
2016 | $65.77M | 1.72% |
2015 | $64.66M | -42.89% |
2014 | $113.23M | -23.16% |
2013 | $147.36M | 164.18% |
2012 | $55.78M | - |